Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

NCT06992596 · Neuralink Corp · Updated 5 June 2025

What is being tested
N1 Implant; R1 Robot
For
Tetraplegia/Tetraparesis; Quadriplegia; Quadriplegia/Tetraplegia; Cervical Spinal Cord Injury; Amyotrophic Lateral Sclerosis (ALS); Spinal Cord Injury (Quadraplegia); Spinal Cord Injury; Motor Neuron Disease; Brain Stem Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 10 people. The full rules are on the registry page.
Where
United Arab Emirates
When
Starts or started 9 May 2025, ends Nov 2027. Registered 28 May 2025.
Results
None posted yet.

In the researchers' words

The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves participants who have tetraparesis, tetraplegia, or a diagnosis that may lead to these conditions. The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.
ClinicalTrials.gov, NCT06992596

Sites

  • Cleveland Clinic Abu Dhabi (CCAD)Abu Dhabi, United Arab Emirates